SBFM logo

Sunshine Biopharma, Inc.

SBFM
Healthcare|Drug Manufacturers - Specialty & Generic|US
$2.71
-0.08 (-2.87%)
Tangible Book / Share
$376.41
Cash / Share
$201.39
Next Earnings Report
Nov 12, 2026
EPS est. -$3.40 · Revenue est. $9.6M
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Oct 9, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
Oct 22, 2026 · Accesswire
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
Oct 9, 2026 · Accesswire
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
Oct 8, 2026 · Accesswire
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
Sep 24, 2026 · Accesswire
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
Sep 16, 2026 · Accesswire
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
Aug 31, 2026 · Accesswire
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
Aug 26, 2026 · Accesswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
Aug 19, 2026 · Accesswire

SEC Filings (75)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 27, 2026DEF 14CDocumentIndex
Oct 14, 2026PRE 14CDocumentIndex
Oct 14, 20268-KMaterial eventDocumentIndex
Oct 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 9, 20268-KMaterial eventDocumentIndex
Oct 9, 2026424B4Offering prospectusDocumentIndex
Oct 7, 2026EFFECTDocumentIndex
Oct 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 2, 2026S-1IPO / offering registrationDocumentIndex
Sep 28, 2026DEF 14CDocumentIndex
Sep 16, 2026PRE 14CDocumentIndex
Sep 16, 20268-KMaterial eventDocumentIndex
Sep 11, 20268-KMaterial eventDocumentIndex
Sep 8, 2026EFFECTDocumentIndex
Sep 8, 2026424B3Offering prospectusDocumentIndex
Aug 28, 2026S-1IPO / offering registrationDocumentIndex
Aug 28, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 3, 20268-KMaterial eventDocumentIndex
Jul 20, 2026424B5Offering prospectusDocumentIndex
Jul 20, 20268-KMaterial eventDocumentIndex
Jul 10, 20268-KMaterial eventDocumentIndex
Jul 8, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 8, 2026DEF 14CDocumentIndex
May 29, 2026PRE 14CDocumentIndex
May 29, 20268-KMaterial eventDocumentIndex
May 22, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 21, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 19, 20268-KMaterial eventDocumentIndex
May 19, 2026424B4Offering prospectusDocumentIndex
May 18, 2026EFFECTDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 12, 2026S-1IPO / offering registrationDocumentIndex
Apr 28, 2026DRSDocumentIndex
Apr 9, 20268-KMaterial eventDocumentIndex
Apr 3, 202610-KAnnual reportDocumentIndex
Mar 31, 2026NT 10-KDocumentIndex